Why a test tube baby is the most exciting thing in life
It’s hard to believe, but a test-fertility treatment is the only thing that could possibly make a kid want to become a doctor.
In a new TEDx talk titled “Test Tube Babies Are Here To Stay,” the inventor of the new treatment, Dr. Robert D’Ambrosio, tells a story of a young man with Down syndrome who, with his mother, decided to become the first in his family to undergo a medical test.
The next day, he had a healthy baby.
A life-changing diagnosis: the boy had a rare genetic disorder called Tay-Sachs disease, which affects a portion of the brain called the hippocampus.
“I didn’t know what Tay-sachs was, but I knew that if I had it, I would be able to do something to change the course of my life,” says D’Amrosio.
The child who would become D’Arbanio is now the youngest person ever to be treated for Tay-sam, and the first to have a child with the condition.
It was a life-altering moment for the young man, but the story is only beginning.
“The test tube kid is here to stay,” says Dr. D’Amaro, who is also the CEO of The New England Bio Center, a fertility clinic in Massachusetts.
The TEDx Talk discusses the scientific breakthroughs made by Dr. Arbanio and how this is just the beginning.
D-Ambrosian, who has also founded a startup called Test Tube Labs, says that while many of the test tube babies in the U.S. are already in their early 20s, the trend is moving in the opposite direction.
“With this type of research, we are in a phase where the next generation of test tube kids is not going to be able find a way to live their lives without a test,” says the inventor.
The goal of the company, D’Artroios says, is to bring the next wave of test-tubes to the U, where they will have a greater chance of surviving.
DART has partnered with the University of Massachusetts Medical School to help fund the development of the technology.
“We’re excited to bring these kids into the world and help them become part of a thriving population,” says Kevin Siegel, DART’s chief operating officer.
As of June 30, there are about 30,000 test-tub baby registries in the United States.
“It’s the beginning of something new,” says Siegel.
The New York Times recently published a profile of D’Anastasio, in which he talked about his family’s life and career journey.
The man behind the idea has become one of the most influential in the world of test tubes, and he says that the next big step is to create a new generation of medical breakthroughs that will benefit everyone, regardless of their genetic make-up.
“When the human genome is mapped, we can start to understand more about the way that different genes and DNA affect health, life, and behavior,” says Aimee Sauer, founder of The Aimees Foundation, a philanthropic organization dedicated to bringing test tube research to the masses.
Sauer has already raised about $1 million for her own research into the genetics of testtube babies.
“What we’re really excited about is to make a vaccine that will be as safe as possible,” says she.
The Foundation also recently invested $1.8 million in the startup incubator incubator, which was founded by D’Apartment Therapy founder and former Harvard University professor Andrew Weil, who founded his first startup, AptoLab.
The incubator will eventually be used to develop products that could treat people with genetic conditions like Tay-Sam, Tay-Gaston, and Tay-Nau.
“A lot of these tests are very invasive, and there are very few tests that actually have a high-quality outcome,” says Weil.
The new incubator has also launched a new research project called Tandem.
The group aims to develop a new test tube test for the treatment of Tay-Dos syndrome, which is a rare disorder in which the cells of the immune system fail to make antibodies against the disease.
The first results of the research are expected this year, and a full-scale test will be launched in 2018.
Domingo D’Espina, the founder and CEO of the New EnglandBio Center, says his team has been working with the NIH and other private companies to develop the technology, which could be a game-changer for the test-lab world.
Drexel University geneticist Dr. Jeffrey Gershenfeld is also working on a new technology to make test tube tests cheaper.
He is working with other test tube companies to make them more affordable.
“Our goal is to eliminate the need for tests like the CT scan or mamm